The Scotts Miracle-Gro (SMG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
4 Feb, 2026Executive summary
Strategic focus on long-term value creation, with a multi-year growth plan targeting $1B in incremental sales and $1B in EBITDA by 2030, and major investments in innovation, marketing, automation, and technology, with annual investments approaching $1B.
Reaffirmed fiscal 2026 guidance and continued progress on Hawthorne divestiture, now classified as a discontinued operation, with closing expected in fiscal Q2 2026.
U.S. Consumer sales on track for low single-digit net sales growth; e-commerce POS dollars grew 12% and units 17% year-over-year.
Board approved a $500M multi-year share repurchase program to begin in late 2026, aiming to reduce share count to 40M, aligned with leverage reduction and capital priorities.
Retailers are building healthy inventory levels ahead of the 2026 lawn and garden season.
Financial highlights
Q1 net sales (excluding Hawthorne) were $354.4M, down 3% year-over-year; U.S. Consumer sales reached $328.5M, with e-commerce and branded product growth remaining strong.
GAAP gross margin rate was 25%, up 90 bps year-over-year; adjusted gross margin was 25.4% vs. 24.5% prior year.
Non-GAAP adjusted EBITDA for Q1 was $3M, up from $0.9M year-over-year, ahead of expectations due to timing of sales.
GAAP net loss from continuing operations was $47.8M ($0.83/share) vs. $66.1M ($1.15/share) prior year; adjusted loss was $44.6M ($0.77/share) vs. $50.2M ($0.88/share) prior year.
Interest expense fell 20% year-over-year to $27.2M; leverage ratio improved to 4.03x from 4.52x.
Outlook and guidance
Fiscal 2026 guidance: U.S. Consumer net sales growth in low single digits, adjusted gross margin rate of at least 32%, adjusted EPS of $4.15–$4.35, mid-single digit adjusted EBITDA growth, and $275M free cash flow.
Leverage ratio targeted to decline to high threes by year-end, below 3.5x by end of FY27.
Management expresses high confidence in outperforming guidance, with incentive plans requiring outperformance for full payout.
Long-term plan targets 5% annual top-line growth through innovation, pricing, volume, and modest M&A.
Sale of Hawthorne business expected within twelve months, representing a strategic shift.
Latest events from The Scotts Miracle-Gro
- Margin expansion, $150M supply chain savings, and 3% sales growth drive future value.SMG
Investor Day 20243 Feb 2026 - Q3 sales and margins surged, with net income and guidance both sharply improved.SMG
Q3 20242 Feb 2026 - All proposals passed and financial performance showed marked improvement.SMG
AGM 20262 Feb 2026 - Margin gains, innovation, and free cash flow drive a positive outlook despite topline shifts.SMG
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 20% EBITDA growth, strong cash flow, and margin gains signal a robust turnaround.SMG
Q4 202416 Jan 2026 - Financial turnaround, board refreshment, and all proposals approved amid strong shareholder support.SMG
AGM 20259 Jan 2026 - Q1 sales and margin gains, U.S. Consumer up 11%, Hawthorne down 35%, outlook reaffirmed.SMG
Q1 20259 Jan 2026 - Strong margin and EPS growth in 2025, with further gains and buybacks expected in 2026.SMG
Q4 202529 Dec 2025 - Proxy covers director elections, pay, auditor ratification, and incentive plan amendment.SMG
Proxy Filing17 Dec 2025